Can eye drops and special glasses stop Kids' nearsightedness from getting worse?
NCT ID NCT06523504
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests whether low-dose atropine eye drops (0.02% or 0.04%) combined with special glasses (DIMS) can slow the progression of moderate to high myopia (nearsightedness) in children aged 6 to 12. About 410 children will be assigned to different treatment groups and followed for changes in eye length and prescription. The goal is to find a safe, effective way to control myopia and reduce future eye health risks.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
atropine eye drops (0.02% and 0.04%) and defocus incorporated multiple segments (DIMS) glasses
What this could lead to
If successful, this could offer a safe, non-surgical way to slow down worsening nearsightedness in children, reducing their risk of eye problems later in life.
What could go wrong
This is an early-phase trial (Phase 1/2) with a moderate number of participants. The treatments may not work better than existing options, and atropine can cause side effects like light sensitivity or blurry near vision.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYOPIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Tianjin Medical University Eye Hospital
RECRUITINGTianjin, Tianjin Municipality, 120120, China
Contact